Objective To explore the clinical efficacy of the Bakri intrauterine balloon (BIUB) in preventing and treating postpartum hemorrhage(PPH) caused by different etiologies.
Methods A retrospective study was conducted on 724 postpartum hemorrhage patients treated at 31 hospitals across 9 provinces in China from November 2018 to September 2019. Clinical data included age, height, pre-pregnancy weight, parity, gestational age at delivery, pregnancy complications and comorbidities was collected. Patients were divided into three groups based on PPH etiology: (1) Group A, with 308 cases of PPH caused by uterine atony; (2) Group B, 211 cases of PPH caused by placental factors; (3) Group C, 205 cases of PPH caused by coagulation dysfunction. General situation, bleeding volume before and after balloon placement, changes in related indicators of blood routine examination, and hemostatic efficacy of Bakri balloon were compared among groups.
Results (1) General situation: There were statistically significant differences in the average age [(31.43±4.95)years vs(32.27±4.82)years vs(33.17±5.07)years, P<0.001)], twin pregnancy [62 (20.13%) vs 11 (5.21%) vs 21 (10.24%), P<0.001], gestational weeks of delivery [(37.39±2.75)weeks vs (36.13±2.56)weeks vs (36.62±2.56) weeks, P<0.001], preterm delivery [76 (24.68%) vs 83 (39.34%) vs 79 (38.54%), P<0.001], cesarean delivery [215 (69.81%) vs 178 (84.36%) vs 150 (73.17%), P<0.001], prenatal red blood cell count [(3.92±0.63)×1012/L vs (3.74±0.69)×1012/L vs (3.79±0.67)×1012/L, P=0.007], hemoglobin [(111.98±16.18)g/L vs (108.66±15.92)g/L vs (107.00±19.76)g/L, P=0.006], hematocrit [(0.35±0.09)%vs (0.34±0.07)% vs(0.33±0.06)%, P=0.033], and mean corpuscular volume(MCV) levels [(86.46±11.20)fl vs (89.04±7.21)fl vs (85.55±11.97)fl, P=0.002] among the three groups of patients. No statistically significant difference were found in pre-pregnancy weight, parity, prenatal mean corpuscular hemoglobin(MCH), mean corpuscular hemoglobin concentration(MCHC), and pre-balloon hemorrhage (P>0.05). (2) Changes in blood routine related indicators: There were no statistically significant changes in red blood cell count, hemoglobin, hematocrit, average red blood cell volume, and average red blood cell hemoglobin concentration among the three groups of patients before and after balloon placement (P>0.05). (3) Hemostatic effect: hemostatic success rates after balloon placement were 98.05%, 97.63%, and 96.59%, respectively. There was no significant difference in the success rate and incidence of complications of Bakri balloon hemostasis among the three groups of patients (P>0.05).
Conclusions The Bakri balloon effectively achieves rapid hemostasis for PPH caused by uterine atony, placental factors, and coagulation dysfunction, demonstrating particular suitability for uterine atony. However, its efficacy is limited in cases of severe PPH.